Cocrystal Pharma, Inc. (COCP)
1.135
+0.02
(+2.25%)
USD |
NASDAQ |
Aug 25, 16:00
1.135
0.00 (0.00%)
After-Hours: 19:59
Cocrystal Pharma Debt to Equity Ratio : 1.284 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.284 |
| March 31, 2026 | 0.346 |
| December 31, 2025 | 0.2377 |
| September 30, 2025 | 0.2064 |
| June 30, 2025 | 0.3109 |
| March 31, 2025 | 0.2373 |
| December 31, 2024 | 0.1896 |
| September 30, 2024 | 0.1476 |
| June 30, 2024 | 0.1024 |
| March 31, 2024 | 0.0807 |
| December 31, 2023 | 0.0702 |
| September 30, 2023 | 0.0038 |
| June 30, 2023 | 0.0051 |
| March 31, 2023 | 0.0068 |
| December 31, 2022 | 0.0075 |
| September 30, 2022 | 0.0082 |
| June 30, 2022 | 0.0085 |
| March 31, 2022 | 0.0065 |
| December 31, 2021 | 0.0069 |
| September 30, 2021 | 0.0073 |
| June 30, 2021 | 0.0057 |
| March 31, 2021 | 0.0104 |
| December 31, 2020 | 0.0114 |
| September 30, 2020 | 0.013 |
| June 30, 2020 | 0.0191 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0177 |
| December 31, 2019 | 0.0318 |
| September 30, 2019 | 0.0129 |
| June 30, 2019 | 0.0139 |
| March 31, 2019 | 0.0149 |
| December 31, 2018 | 0.0049 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0196 |
| December 31, 2017 | 0.0096 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.0146 |
| Fulcrum Therapeutics, Inc. | 0.017 |
| Definium Therapeutics, Inc. | 0.0397 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.649M |
| Total Liabilities (Quarterly) | 3.605M |
| Shareholders Equity (Quarterly) | 1.044M |
| Current Ratio | 1.237 |
| Net Debt Paydown Yield | 0.54% |